
HIMS Stock Forecast & Price Target
HIMS Analyst Ratings
Bulls say
Hims & Hers Health Inc. demonstrated robust financial performance with a total revenue growth of 95.1% year-over-year, driven by a significant increase in online revenue, which rose 98.3% to $470.8 million. The company experienced substantial subscriber growth, adding 182,000 in the quarter, bringing the total to 2.2 million, which represents a 45.0% increase year-over-year. Management's expectation for the weight loss business to constitute approximately 30% of FY25 revenue, alongside a growing trend towards premium personalized offerings, highlights the company’s strategic positioning for continued growth and profitability.
Bears say
Hims & Hers Health Inc is facing significant headwinds due to rising costs and increased competition from venture-backed companies that can undercut pricing, threatening the company’s market share and squeezing profit margins. Additionally, the company experienced a decline in gross margins in Q4, attributed to a less favorable product mix and lower pricing on certain offerings, which, combined with higher marketing costs, may further strain operating margins. The current valuation appears stretched at more than 4x EV/Sales based on management's guidance, leaving little room for favorable adjustment in the stock price following an approximate 18% drop after hours.
This aggregate rating is based on analysts' research of Hims & Hers Health and is not a guaranteed prediction by Public.com or investment advice.
HIMS Analyst Forecast & Price Prediction
Start investing in HIMS
Order type
Buy in
Order amount
Est. shares
0 shares